D. E. Shaw & Co., Inc. - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 125 filers reported holding TREACE MED CONCEPTS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$894,744
-85.5%
68,249
-71.7%
0.00%
-83.3%
Q2 2023$6,163,834
+76.0%
240,963
+73.3%
0.01%
+50.0%
Q1 2023$3,503,022139,0640.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q1 2023
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,537,271$38,723,8564.26%
Millrace Asset Group, Inc. 72,595$1,8292.13%
Divisadero Street Capital Management, LP 175,000$4,408,2501.93%
Perceptive Advisors 2,442,250$61,520,2781.82%
SECTORAL ASSET MANAGEMENT INC 366,443$9,230,6991.77%
EMERALD MUTUAL FUND ADVISERS TRUST 1,120,875$28,234,8411.67%
EMERALD ADVISERS, LLC 1,363,453$34,345,3811.65%
FORMULA GROWTH LTD 124,900$3,146,2311.01%
Novo Holdings A/S 540,000$13,602,6000.90%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 755,379$19,027,9970.78%
View complete list of TREACE MED CONCEPTS INC shareholders